Shanghai Micurx Pharmaceutical Co., Ltd. Class ASSE: 688373

"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Progress of Litigation Involving a U.S. Subsidiary

Sep 25, 2026 · Issued by Shanghai Micurx Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Progress of Litigation Involving a U.S. Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shanghai Micurx Pharmaceutical Co., Ltd. Class A

"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Shareholding Reduction Plan of ShareholderSep 23
"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Expiration of Shareholding Reduction Plan by Shareholder and Results of Shareholding ReductionSep 10
"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 5
"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026Aug 26

All Shanghai Micurx Pharmaceutical Co., Ltd. Class A news releases